Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Myriad Genetics Falls After Sanofi Setback for Cancer Treatment
Myriad Genetics Falls After Sanofi Setback for Cancer Treatment
Myriad Genetics Falls After Sanofi Setback for Cancer Treatment
Submitted by
admin
on January 28, 2011 - 12:09pm
Source:
Bloomberg
News Tags:
Myriad Genetics
Sanofi
BSI-201
breast cancer
Headline:
Myriad Genetics Falls After Sanofi Setback for Cancer Treatment
Do Not Allow Advertisers to Use My Personal information
